Search Results for: rmat

Advanced Cell Technology and Geron: allies or competitors?

Geron-300x2212

Two companies, Advanced Cell Technology (ACT) and Geron, both HQ’d here in California, have FDA-approved early stage clinical trials in the works. Geron’s trial has already started and reportedly now has enrolled at least two patients. The trial is of course for the safety of Geron’s GRNOPC1 oligodendrocyte product made from human ES cells for […]

Advanced Cell Technology and Geron: allies or competitors? Read More »

Lisa Ray, Stem Cell City, and stem cell resources across the globe

The McEwen Centre for Regenerative Medicine has launched a new effort they call “Stem Cell City”. As part of the launch they have enlisted the help of Lisa Ray, a Canadian Actress/Model, who was treated for Multiple Myeloma in 2009 using a stem cell transplant. Lisa Ray has a video that is quite compelling (see

Lisa Ray, Stem Cell City, and stem cell resources across the globe Read More »

Launching SCOPE: Stem Cell Outreach Program for Education

Today, I am launching a new effort called Stem Cell Outreach Program for Education  (SCOPE). I think stem cell technology will transform medicine across the globe, but it will take a concerted effort to make certain that stem cell-based therapies do not become a type of medicine only available to the relatively wealthy or predominantly available

Launching SCOPE: Stem Cell Outreach Program for Education Read More »

Stem cells gone wild? What really happens after a transplant

Geron-300x2212

What really happens to cells after they a stem cell transplant into a patient? Once these cells, which have spent weeks in a lab environment, are injected into a person, what happens next? This is arguably the most important question in the regenerative medicine field, but there are few answers. We are literally mostly in

Stem cells gone wild? What really happens after a transplant Read More »

Why miRNA iPS cells might be the ticket: an A+ paper

Since Yamanaka’s discovery of iPS cells first in mouse and then in human cells 5 years ago, both made using viral transduction, a host of new methods to make iPS cells have been reported.  These methods are quite diverse, ranging from transposons, to recombinant proteins, to plasmids, and to RNA.  Often times these new approaches

Why miRNA iPS cells might be the ticket: an A+ paper Read More »